ARK Invest's position in LLY, updated every trading day. Data as of 2026-11-12.
| Fund | Shares | Value | Weight | Rank |
|---|---|---|---|---|
| ARKG | 64,309 | $91.7M | 4.64% | #7 |
| Trade day | Fund | Side | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-06 | ARKK | Sell | Closed position | 398 | $543K |
| 2026-11-05 | ARKK | Sell | Trimmed | 977 | $1.3M |
| 2026-11-05 | ARKG | Sell | Trimmed | 5,655 | $7.7M |
| 2026-11-04 | ARKK | Sell | Trimmed | 8,551 | $12.1M |
| 2026-10-30 | ARKK | Sell | Trimmed | 17,626 | $25.0M |
| 2026-07-20 | ARKG | Buy | Added | 2,730 | $3.1M |
| 2026-07-08 | ARKG | Buy | Added | 14,637 | $17.8M |
| 2026-07-07 | ARKG | Buy | Added | 6,354 | $7.9M |
| 2026-06-25 | ARKG | Buy | Added | 726 | $819K |
| 2026-06-24 | ARKG | Buy | Added | 7,293 | $8.1M |
| 2026-06-18 | ARKK | Buy | Added | 2,448 | $2.7M |
| 2026-06-18 | ARKG | Buy | Added | 6,039 | $6.6M |
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N,…
See LLY's full ARK history since 2024, ARK's estimated cost basis, the conviction score and buy/sell alerts.
Open LLY on FundWake →Data comes from ARK Invest's public daily holdings and trade files. FundWake is not affiliated with ARK Invest. Nothing here is investment advice.